Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score

Tomoki NakamuraDepartment of Orthopedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, 514-8507, JapanCorrespondence[email protected]

https://orcid.org/0000-0002-1099-7436

Kunihiro AsanumaDepartment of Orthopedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, 514-8507, Japan

Tomohito HagiDepartment of Orthopedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, 514-8507, Japan

Akihiro SudoDepartment of Orthopedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, 514-8507, Japan

Pages 3891-3899 | Published online: 11 Jul 2022

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353:701–711. doi:10.1056/NEJMra041866
PubMed Web of Science ®Google Scholar
Nakamura T, Asanuma K, Takao M, et al. Clinical outcome in patients with soft tissue sarcoma who received metastasectomy and/or radiofrequency ablation: Tokai Musculoskeletal Oncology Consortium study. Cancer Manag Res. 2021;13:8473–8480. doi:10.2147/CMAR.S333721
PubMed Web of Science ®Google Scholar
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720
PubMed Web of Science ®Google Scholar
Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-3
PubMed Web of Science ®Google Scholar
Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4(1):17105. doi:10.1038/nrdp.2017.105
PubMed Web of Science ®Google Scholar
Eckart A, Struja T, Kutz A, et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a Prospective Study. Am J Med. 2020;133(6):713–722.e7. doi:10.1016/j.amjmed.2019.10.031
PubMed Web of Science ®Google Scholar
Forrest LM, McMillan DC, McArdle CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028–1030. doi:10.1038/sj.bjc.6601242
PubMed Web of Science ®Google Scholar
McMillan DC, Crozier JE, Canna K, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22(8):881–886. doi:10.1007/s00384-006-0259-6
PubMed Web of Science ®Google Scholar
Takeno S, Hashimoto T, Shibata R, et al. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology. 2014;87(4):205–214. doi:10.1159/000362601
PubMed Web of Science ®Google Scholar
Nakamura T, Matsumine A, Asanuma K, et al. The value of high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Bone Joint J. 2015;97-B(6):847–852. doi:10.1302/0301-620X.97B.35098
PubMedGoogle Scholar
Hou T, Guo T, Nie R, et al. The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma. Eur J Surg Oncol. 2020;46(8):1496–1502. doi:10.1016/j.ejso.2020.05.026
PubMed Web of Science ®Google Scholar
Nakamura T, Matsumine A, Matsubara T, et al. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer. 2012;118(4):1055–1061. doi:10.1002/cncr.26353
PubMed Web of Science ®Google Scholar
Nakamura T, Grimer R, Gaston C, et al. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Eur J Cancer. 2013;49(2):377–385. doi:10.1016/j.ejca.2012.09.004
PubMed Web of Science ®Google Scholar
Wang X, Liu S, Zhao X, et al. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: a meta-analysis. PLoS One. 2019;14(7):e0219215. doi:10.1371/journal.pone.0219215
PubMed Web of Science ®Google Scholar
Errani C, Cosentino M, Ciani G, et al. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases. Int Orthop. 2021;45(5):1337–1346. doi:10.1007/s00264-020-04921-2
PubMed Web of Science ®Google Scholar
McMillan DC, Watson WS, O’Gorman P, et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39(2):210–213. doi:10.1207/S15327914nc392_8
PubMed Web of Science ®Google Scholar
Hirahara N, Matsubara T, Kaji S, et al. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score. Oncotarget. 2020;11(45):4169–4177. doi:10.18632/oncotarget.27796
PubMedGoogle Scholar
Ando K, Sakamoto S, Saito S, et al. Prognostic value of high-sensitivity modified Glasgow prognostic score in castration-resistant prostate cancer patients who received docetaxel. Cancers. 2021;13(4):773. doi:10.3390/cancers13040773
PubMed Web of Science ®Google Scholar
Spense S, Doonan J, Farhan-Alanie OM, et al. Does the modified Glasgow prognostic score aid in the management of patients undergoing surgery for soft-tissue sarcoma?: An international multicentre study. Bone Joint J. 2022;104-B(1):168–176. doi:10.1302/0301-620X.104B1.BJJ-2021-0874.R1
PubMed Web of Science ®Google Scholar
Callegaro D, Miceli R, Bonvalot S, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17(5):671–680. doi:10.1016/S1470-2045(16)00010-3
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date